ArticleKidney international reports2025

Anti-CD38 Daratumumab Treatment of Chronic Active Antibody-Mediated Kidney Allograft Rejection.

Wai-Choong Lye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.